Oral GLP-1s Won’t Win on Convenience – They’ll Win on CMC
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
False
Advertisement
Related Content
Development & Clinical
Formulation
Biopharma
Analytical Champions: Sarah O’Keeffe
November 10, 2026
14 min read
Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
Drug Delivery
Interviews
Putting Patients in Control of Self-Injection
November 4, 2026
5 min read
West Pharmaceutical Services’ Whitney Winters discusses how injection device design can support patient comfort, confidence, and independence
Formulation
Small Molecules
Development & Clinical
Strategic Development of Complex Oral Therapies
November 2, 2026
5 min read
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies
Biopharma
Drug Delivery
Development & Clinical
Staying the Course: Sitting Down With Mike Cooke
October 29, 2026
9 min read
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain